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Abstract
Objectives: Hypertension is the leading cause of HF in sub-Saharan Africa. Electrocardiography (ECG) is a cheap and
easily available stratiﬁcation tool for the diagnosis and prognostication of individuals with hypertension. The aim of this
study was to develop an ECG-based HF diagnostic score among patients with hypertension attending a specialist cardiology clinic.
Methods: One hundred and one (101) case-control age- and sex-matched pairs were recruited. The study population
were adults with a clinical diagnosis of hypertensive HF failure (cases) and systemic hypertension without HF (controls).
Participants underwent clinical assessment and ECG. Associations between ECG variables and HF risk were tested with
chi square test. Logistic regression modelling (age- and sex adjusted) was trained on a random subset of participants and
tested on the remaining participants to determine the ECG abnormalities that are diagnostic of HF and develop a HF
diagnostic score. The HF diagnostic score was then validated in an independent dataset of the ECG-Hypertension Audit.
Goodness of ﬁt and c-statistics of the HF summed diagnostic score in the training, testing and validation datasets are
presented. A two-sided p value of <0.05 was considered statistically signiﬁcant.
Results: The independent ECG diagnostic markers of HF among hypertensive patients in this study in decreasing order
of effect size were sinus tachycardia (aOR: 7.72, 95% CI: 2.31-25.85). arrhythmia (aOR: 7.14, 95% CI: 2.57-19.86), left
ventricular hypertrophy (aOR: 4.47; 1.85-10.77) and conduction abnormality (aOR: 3.41, 95% CI: 1.21-9.65). The HF
summed diagnostic score showed excellent calibration and discrimination in the training (Hosmer Lemeshow p¼0.90; cstatistic 0.82; 95% CI 0.76e0.89) and test samples (Hosmer Lemeshow p¼0.31; c-statistic 0.73 95% CI 0.60 to 0.87) of the
derivation cohort and an independent validation audit cohort (Hosmer Lemeshow p¼0.17; c-statistic 0.79 95% CI 0.74 to
0.84) respectively. The model showed high diagnostic accuracy in individuals with different intermediate pre-test
probabilities of HF.
Conclusions: A ECG based HF score consisting of sinus tachycardia, arrhythmia, conduction abnormality and left
ventricular hypertrophy is diagnostic of HF especially in those with intermediate pre-test probability of HF. This has
clinical importance in the stratiﬁcation of individuals with systemic hypertension.
Keywords: Hypertensive HF, Sinus tachycardia, Arrhythmia, Conduction abnormalities, Left ventricular hypertrophy
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1. Introduction

H

ypertension is the leading risk factor for
cardiovascular diseases and cardiovascular
related morbidity and mortality globally and is
responsible for about 7.6 million deaths every
year worldwide [1]. It is the leading cause of HF
(HF) globally and especially in sub-Sahara Africa.
Hypertension is the most frequent cause of HF in
Nigeria accounting for up to 61% in a cohort in
Abuja and 75.7% in another cohort of HF group in
Ibadan, Nigeria [2,3]. Despite improvement in
care of patients with systemic hypertension and
development of potent anti-hypertensives, HF
incidence continues to rise even in Nigeria [4].
Hypertensive HF predominantly affect younger
age group in African populations thus leading to
loss of economic productivity and poor quality of
life [4,5].
Hypertensive HF continues to be a common presentation in clinical cardiology practice. The identiﬁcation and appraisal of low cost, reliable and
simple bedside tests to aid the identiﬁcation, stratiﬁcation and risk assessment of patients presenting
with clinical features of HF especially in hypertensive heart disease has been an area of active investigation [6e8]. The management of such patients has
usually been based on clinical signs, serum
biochemistry, electrocardiography and echocardiography. While echocardiography has changed the
landscape of clinical assessment of patients with
suspected heart failure, electrocardiography remains an important assessment and stratiﬁcation
tool in the care of patients with heart diseases
especially HF.
Electrocardiography is particularly useful in the
early detection of arrhythmias, myocardial ischemia
and chamber enlargement and hypertrophy which
are poor prognostic factors in HF [9]. Electrocardiography is also sensitive in the detection of cardiovascular morbidities and has high negative
predictive value in the assessment of patients with
HF signs [7,10e12]. While HF diagnosis in specialist
settings can be made with the help of echocardiography and novel markers like N-terminal Pro-BNP,
this is not the case in low resource settings where
electrocardiography may be very useful in characterizing such patients and in some cases, ascertaining the trigger and precipitant of HF. Abnormal
electrocardiographic patterns are particularly common in patients with HF. Studies have shown that
up to 93% of HF patients have abnormal
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electrocardiographic patterns [13]. Electrocardiographic left ventricular hypertrophy, arrhythmias
and conduction abnormalities have been shown to
be independent predictors of poor functional status
and morbidity in HF patients.
Most studies on clinical electrocardiography in
Nigeria have been descriptive studies in patients
with hypertension and hypertensive heart disease
[8,14,15]. Okeahialam et al. reported 10%
arrhythmia among hypertensives with the common
arrhythmias being ventricular ectopics, atrial ectopics and atrial ﬁbrillation [16]. Electrocardiographic left ventricular hypertrophy has been
reported in 18%e56% in different studies [16]. Few
studies in Nigeria have assessed electrocardiographic predictors of HF in patients with HF especially hypertensive HF. Dzudie et al. [6] in the
largest HF study in Africa till date, the THESUS-HF
study found a prevalence of 97.7% of abnormal
ECGs with increasing heart rate and atrial ﬁbrillation on ECG tracings predicting worse clinical outcomes. However, this study contained a
heterogeneous population of HF of different aetiologies. Only 43.2% of the study population were
hypertensive HFs. Little is known till date about the
unique ECG predictors of hypertensive HF in Africans and Nigerians in particular. Most of the studies
done in this area in Nigeria and other sub-Saharan
countries have been largely descriptive. Preventive
and primary health approach to reducing the
scourge of HF in patients with hypertension would

beneﬁt from early detection and identiﬁcation of
simple diagnostic predictors of HF in at risk populations using low-cost technologies like the ECG.
The RISK-HHF study is a caseecontrol study
designed as an initial step in the determination and
characterization of the risk factors and diagnostic
markers of hypertensive HF in Nigerian-Africans.
We included 102 patients with hypertensive HF and
similar number of age and sex-matched hypertensive controls without HF. The speciﬁc objectives
were to characterize the ECG patterns in individuals
with hypertensive HF compared to those with hypertension, and also to develop and evaluate the
performance of a regression model of electrocardiographic patterns diagnostic of HF in individuals
with hypertension.

2. Materials and methods
2.1. Participants
This study was approved by the joint University of
Ibadan and University College Hospital Institutional
Review Board (IRB) and complied with the principles outlined in the declaration of Helsinki [17]. The
study also adhered to the STROBE guidelines on
observational studies [18]. Written informed consent
as approved by the IRB was obtained from all study
participants.
2.2. RISK-HHF participants
Participants were recruited from the cardiology
clinic and medical wards of the Department of
Medicine, University College Hospital, Ibadan.
Participants recruitment started in June, 2018 and
the whole study lasted about 8 months. Patients
aged 18 years old or above with clinical diagnosis of
HF secondary to hypertension who were attending
the hospital for the ﬁrst time were recruited into the
study as cases while age (5-year age range) and sex
matched hypertension with no HF served as controls. Exclusion criteria for both cases and controls
were HF diagnoses of other aetiologies, previous
myocardial infarction or history of ischaemic heart
disease, chronic obstructive pulmonary disease,
being pregnant and consumption of 80 g of alcohol
per day for the past 5 years.
Clinical diagnosis of HF was based on the modiﬁed Framingham criteria [19]. A patient was
considered to have HF secondary to hypertension
on the basis of self-reported history of hypertension
and/or the use of blood pressure-lowering medication or documented blood pressure  140/90 mmHg
[4].
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Sample size (N) in each group was calculated
using the formula for case control study [20].
N ¼ [Z1-a/2√2p(1-p) þ Z1-b√p1(1-p1)þp2(1p2)]2∕(p1-p2)2
Z1-a/2, standard normal deviate at a of 0.05 ¼ 1.96
Z1-b at 95% power ¼ 1.64
p1, is the prevalence of electrocardiographic LVH
(dominant marker) in hypertensives in HF in Agomuoh and Odia [8] ¼ 49.3%
p2, is the prevalence of electrocardiographic LVH
in hypertensives without HF in Agomuoh and Odia
[8] ¼ 22%
p¼ (p1þp2)/2;
Thus, N ¼ 78.5, adding a non-response rate of
25%, N becomes 98. One hundred and one (101)
participants were recruited consecutively into each
group from the study sites.
2.3. Procedures
A semi structured interviewer administered questionnaire was used for data collection. The questionnaire was developed and modiﬁed from a previous
study and followed the STEPS format for epidemiologic surveys [21]. The questionnaire had three sections; sections A, B and C. Section A was divided into
subsections on demographic data, medical history,
lifestyle risk factors, symptoms and size, medications
in use, examination and laboratory test results. Section B was the assessment of medication adherence
using the Medication Adherence Questionnaire [22].
Section C contained the coding of electrocardiographic patterns according to the modiﬁed Minnesota coding system [23,24]. The questionnaire was
pre-tested before the main study among 10 cases and
10 controls. The questionnaire was also translated
into the Yoruba language which is the local language
spoken by most patients attending the hospital.
Baseline clinical and demographic data was obtained from the subjects. Blood pressure measurements
were
obtained
with
a
mercury
sphygmomanometer according to standard guidelines [25]. Systolic and diastolic blood pressure were
measured at Korotkoff sounds phase I and V,
respectively. Two readings were taken at intervals of
at least 2 min, and the average of the readings was
used to represent the patient's blood pressure [26]. If
there is > 5 mm Hg difference between the ﬁrst and
second readings, additional (1 or 2) readings was
obtained, and then the average of these multiple
readings was used [27,28].
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Subjects were weighed without shoes and in light
clothing on a standard beam balance. Height was
measured to the nearest centimetre using anthropometrical plane with subjects not putting on shoes
or headgear [29].
Body mass index (BMI) was calculated using the
formula:
BMI¼Weight (Kg)/Height2 (m2)
Patients had full cardiovascular examination
done. Patients with any of pedal oedema, abdominal
distension, engorged neck veins, orthopnoea,
paroxysmal nocturnal dyspnoea, basal lung crackles
and rales were considered congested. Venous blood
sample (20 mls) was taken for serum electrolytes,
serum urea, serum creatinine and fasting serum
lipids from each subject along with 5 mls of urine for
dipstick urinalysis. Signiﬁcant proteinuria was
deﬁned as more than trace proteinuria on dipstick
[30]. Electrocardiography and echocardiography
were also done for each study participant. The New
York Heart Association (NYHA) functional class was
assigned at recruitment in those with HF.
2.4. ECG-Hypertension Audit
We recruited 377 individuals with hypertension
from the ECG-Hypertension Audit who were referred
to our ECG laboratory for electrocardiography. These
individuals underwent brief screening questions
about lifestyle cardiovascular risk factors and indications for ECG referral. They also had focused
cardiovascular examination including blood pressure
measurement as earlier described [25,27,28]. This is
the standard procedure in our ECG laboratory. The
ECG-Hypertension Audit was used to validate the
ECG regression model for the diagnosis of HF.
2.5. Electrocardiography
The standard resting 12 lead ECG was performed
on all subjects at a paper speed of 25 mm/s, standardized at 0.1mv/mm and analysed. Electrocardiogram measurements were done with a ruler on the
resting ECG tracings and was expressed as the
average of three determinations on consecutive QRS
complexes [31]. R-wave amplitude in aVL and S-wave
depth in V3 were measured as the distance (mm) from
the isoelectric line of their zenith and nadir, respectively [31,32]. QRS duration was measured from the
beginning to the end of the QRS complex. QRS
duration 0.12s was deﬁned as prolonged. QT interval was calculated as the interval from the beginning
of the QRS to the end of the T wave in seconds while

QTc interval was calculated using the Bazzett's formula. QTc prolongation was deﬁned as a QTc
>450 ms in men and 460 ms in women [31].
Sinus rhythm was deﬁned as a rhythm in which
each QRS complex is preceded by an upright P
wave in Lead II with heart rate 60e100/minute [33].
Sinus Tachycardia is a sinus rhythm with heart rate
greater than 100/minute while sinus bradycardia is
sinus rhythm with heart rate less than 60/minute.
Atrial ﬁbrillation was deﬁned as absence of
discernible P waves in lead II with ﬁbrillary waves
in V1 and irregular RR intervals [33]. Arrhythmia
was deﬁned as the presence of any of atrial premature complexes, premature ventricular complexes or atrial ﬁbrillation.
Left axis deviation was deﬁned as QRS axis of 30 to
90⁰ [33]. Left atrial enlargement (LAE) was diagnosed when P wave duration is  0.12s and/or negative component of P wave in lead V1 greater than
1 mm in depth and/or notched P wave with interpeak
duration > 0.04s (P mitrale) or area of negative P terminal force in lead V1 > 0.04 s mm [34,35]. Left ventricular hypertrophy (LVH) was diagnosed using the
Sokolow-Lyon criteria, Cornell criteria and/or Framingham criteria [31,32,36]. Left bundle branch block
was deﬁned as broad QRS complexes with slurred R
waves in lateral leads, secondary ST depression with
T wave inversion in left lateral leads, deep S waves in
right precordial leads and/or loss of septal Q waves
[32,37]. Right bundle branch block was deﬁned as
broad QRS complexes, delayed intrinsicoid deﬂection
>0.05 in right precordial leads, rSRʹor M pattern in
right precordial leads, secondary ST depression and T
wave inversion in right precordial leads and deep S
waves in left lateral leads [32,37]. Left anterior hemiblock was deﬁned as signiﬁcant left axis deviation
with an initial small q wave and positive QRS complex
in lead I, negative QRS complex in lead II and aVR,
and small r wave in lead III and no other cause for the
left axis deviation [37]. Left posterior hemiblock was
deﬁned as signiﬁcant right axis deviation, a small q
wave in lead III and small r wave in lead I, prominent
S waves in lead I and R waves in leads II and III with
no other cause for the right axis deviation [37]. Conduction abnormality was deﬁned as presence of any
bundle branch block or atrioventricular block. Prolonged QTc interval was deﬁned as QTc interval
450 ms in men and 460 ms in women. A diagnosis
of ischaemic heart disease was made based on the
American Heart Association criteria [31].
2.6. Statistical analysis
Data were analysed using STATA version 12(StataCorp LLC, Lakeway Drive, College Station, Texas,

USA). Normality of data were determined using
ShapiroeWilk test. Proportions were used to summarize categorical variables while continuous clinical variables were summarized as means (standard
deviations).
Hypertension group and hypertensive heart failure group were compared in exploratory analyses
using classical non-regression analyses. Association
between categorical variables and heart failure risk
were determined using chi square test while association between continuous variables and heart
failure risk were determined using independent
sample t-test.
The RISK-HHF dataset was then randomly
divided into training and test datasets in ratio (75:25)
respectively. For the training dataset, univariable
logistic regression model was used to explore the
relationship between various electrocardiographic
patterns and HF risk. Multivariable logistic regression analysis was then used to develop models of
the relationship between ECG variables and HF
risk. Iterative model building was done and
conﬁrmed with forward stepwise selection method.
Only ECG variables which accounted for at least 5%
of the variance in HF and which were signiﬁcant in
univariable logistic regression at 5% signiﬁcance
level using the Wald test were retained in the
multivariable model.
Model discrimination was deﬁned using receiver
operating characteristic curves (ROC) while goodness of ﬁt of the model was assessed using the
HosmereLemeshow statistic. Incremental value of
addition of other ECG variables to the model was
tested with net reclassiﬁcation index (NRI) and integrated discrimination improvement (IDI) programs in stata. A bootstrap analysis of 1000 random
samples of the training dataset was then used to
assess the internal validity of the multivariable
model using the ‘roctab’ command in stata. This
was used to obtain the 95% conﬁdence intervals of
the ROC. A HF summed diagnostic score was then
created with the variables in the multivariable
model based on the strength of association by b
coefﬁcients, as previously described [38]. Using this
summed diagnostic rule score on a continuous scale,
we then evaluated its diagnostic performance by the
area under the receiver-operating characteristic
curve (AUC), or c statistic. We compared the performance of the multivariable model with the
summed diagnostic rule score using the ‘roccomp’
command in stata to test the difference between the
two AUCs. The accuracy of the HF summed diagnostic rule score at different probabilities of HF was
also determined.
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The performance of the summed diagnostic rule
score was then evaluated in the test dataset. The cstatistics was calculated and the ROC of the summed diagnostic rule score in the training dataset was
plotted while the goodness of ﬁt was also determined. Bootstrap analyses of 1000 random samples
of the test dataset were also done as earlier
described. The performance of the HF summed
diagnostic rule score was then conﬁrmed in the
whole dataset of the RISK-HHF study using k-fold
cross validation analyses. The HF summed diagnostic rule score was then validated by applying it to
the independent ECG-Hypertension Audit dataset.
Model discrimination and calibration were also
tested as earlier outlined. The performance and accuracy of the model was also explored across
different ranges of predicted probabilities of HF in
the ECG-Hypertension Audit as earlier described.
Forest plot of the adjusted odds ratio of the ECG
variables was plotted using the ‘ipdmetan’ package
in stata. A p value < 0.05 was considered statistically
signiﬁcant in all analyses.

3. Results
A total of one hundred and one (101) age and sex
matched case control pairs were recruited into the
RISK-HHF study. Table 1 shows the sociodemographic, clinical and electrocardiographic data of the
subjects. The mean age of the subjects was 62.4
years (cases) and 60.7 years (controls) with similar
proportion of males and females.
Also, as shown in Table 1, individuals with HF
were more likely to have lower education attainment, more likely to have history of kidney disease
and also more likely to have ever consumed alcohol.
Conversely, diabetes, obesity and smoking were not
signiﬁcantly associated with HF. Subjects with hypertensive HF had higher pulse rate, but lower
systolic (SBP) and diastolic (DBP) blood pressure
than hypertensive individuals without heart failure.
Furthermore, HF was signiﬁcantly associated with
sinus tachycardia, arrhythmias (including atrial
ﬁbrillation, atrial premature complexes and premature ventricular complexes), conduction abnormalities, left atrial enlargement (LAE) and left
ventricular hypertrophy (LVH) on ECG. Other details are as shown in Table 1.
3.1. Univariable diagnostic predictors of HF
The univariable logistic regression of various
electrocardiographic patterns investigated as potential diagnostic predictors of heart failure in the
training dataset is shown in Table 2. Among the
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Table 1. Baseline characteristics of participants in the RISK-HHF study (data are summarized as % for categorical variables and mean ± SD for
continuous variables).
Variables
Socio-demographic and lifestyle variables
Age
Male
Low education (below tertiary education)
Diabetes
Kidney disease
Obesity
Exercise
Ever smoked
Ever consumed alcohol
Clinical proﬁle
BMI (kg/m2)
Pulse (/min)
SBP (mmHg)
DBP (mmHg)
ECG abnormalities
Sinus tachycardia
Atrial ﬁbrillation
APCs
PVCs
Any arrythmia
Conduction abnormality
LAD
LAE
LVH
QRS duration (ms)
QTc interval (ms)

Cases: HHF (101)

Controls Hypertension without HF (102)

P value

62.4 ± 14.3
50 (49.5)
74 (73.3)
12 (11.9)
11 (10.9)
16 (15.8)
42 (41.6)
15 (14.8)
47 (46.5)

60.7 ± 13.0
50 (49.5)
59 (58.4)
16 (15.8)
2 (3y2.0)
22 (21.8)
47 (46.5)
10 (9.9)
24 (23.8)

0.36
1.00
0.03*
0.41
0.02*
0.28
0.48
0.28
0.001**

27.6 ± 9.4
87.9 ± 15.4
126.8 ± 23.6
79.4 ± 18.3

27.8 ± 6.7
89.3 ± 6.4
145.7 ± 20.1
86.0 ± 19.0

0.83
0.84*
<0.001**
0.01*

28 (27.7)
19 (18.8)
18 (17.8)
24 (23.8)
45 (44.5)
35 (34.6)
53 (52.5)
53 (52.5)
76 (75.2)
110.4 ± 25.2
464.7 ± 66.2

7 (6.9)
2 (2.0)
6 (5.9)
3 (3.0)
11 (10.9)
9 (8.9)
35 (34.6)
39 (38.6)
55 (54.5)
98.8 ± 20.9
447.5 ± 53.0

<0.001**
<0.001**
<0.01*
<0.001**
<0.001**
<0.001**
0.01*
0.05*
<0.01*
<0.001**
0.04*

BMI: body mass index; SBP: systolic blood pressure; DBP: diastolic blood pressure; APCs: atrial premature complexes; PVCs: premature
ventricular complexes; LAD: left axis deviation; LAE: left atrial enlargement; LVH: left ventricular hypertrophy.
Any arrhythmia: deﬁned as any of PACs, PVCs or atrial ﬁbrillation. Conduction abnormality: deﬁned as any of atrioventricular block,
bundle branch blocks or hemiblocks.
*p  0.05; **p  0.001.

ECG variables, sinus tachycardia was associated
with a 7-fold increased risk of Hypertensive HF,
atrial ﬁbrillation was associated with 6.5-folid
increased risk of HHF, premature ventricular complexes (PVCs) was associated with about 12-fold
increased risk of HHF the presence of any arrythmia
was associated with about 7-fold increased risk of
HF. Conduction abnormality was associated with
about 5-fold increased likelihood of HHF while left
atrial enlargement and left ventricular hypertrophy
(LVH) were associated with 2-fold and 3.5-fold
increased risk of HHF respectively. Arrhythmia on
ECG (especially PVCs) and sinus tachycardia
accounted for much of the variance in HHF risk as
shown by the R2 in univariable regression.
3.2. Development of the HF summed diagnostic
score
The multivariable logistic regression model of
electrocardiographic diagnostic predictors of HHF is
shown in the forest plot in Fig. 1 below. In the ageand sex adjusted multivariable model, only sinus

tachycardia, arrhythmia, conduction abnormality
and LVH remained signiﬁcant diagnostic predictors
of HF in hypertension. While the effect sizes of sinus
tachycardia and arrhythmia remained largely the
same, the effect size of conduction abnormality was
attenuated to aOR of 3.4 while that of LVH was
magniﬁed to aOR of 4.5. This model exhibited
excellent calibration (Hosmer Lemeshow goodness
of ﬁt p ¼ 0.90) and discrimination of HF from
Table 2. Univariable logistic regression of electrocardiographic patterns
in training dataset.
variables

OR (95% CI)

P value R2 (%)

Sinus tachycardia
Atrial ﬁbrillation
APCs
PVCs
Any arrythmia
Conduction abnormality
Left axis deviation
Left atrial enlargement
Left ventricular hypertrophy
QRS duration (per ms increase)
QTc duration (per ms increase)

7.32 (2.39e22.41)
6.54 (1.41e30.34)
4.17 (1.31e13.21)
11.59 (2.59e51.81)
6.71 (2.84e15.85)
4.62 (1.94e11.00)
2.17 (1.13e4.18)
2.95 (1.53e5.72)
3.46 (1.74e6.90)
1.02 (1.01e1.04)
1.01 (1.00e1.01)

<0.001
0.02
0.01
0.001
<0.001
0.001
0.02
0.001
<0.001
<0.01
0.05

7.8
3.8
3.3
8.1
11.0
6.6
2.6
5.1
6.2
5.2
2.0
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Fig. 1. Multivariable logistic regression model of electrocardiographic patterns in the training dataset (Odds ratios are age- and sex adjusted). In the
reference population with no sinus tachcyardia, arrhythmia, conduction abnormality or LVH, the odds ratio of HF (i.e the intercept) was 0.09 (95%CI
0.01, 0.81).

controls (c-statistic 0.83; 95% CI 0.76 to 0.89) as
shown in Fig. 2 below. Addition of either of left atrial
enlargement or QTc interval to the model did not
add to the performance of the model in net reclassiﬁcation index and integrated discrimination
improvement analysis.
We generated a summed score based on this
multivariable model by assigning points to each
variable in the model based on the strength of association in logistic regression as measured by the b
coefﬁcients (shown in Table 3). We assigned 2 points
to each of sinus tachycardia and arrhythmia while 1
point each was assigned to each of conduction abnormality and LVH, thus making a total score of 6.
The odds of having HF increased by a factor of 3
(OR 2.96; 95% CI 2.09e4.20) for every unit increase
in the score. The HF summed diagnostic score
provided strong discrimination of HF from controls
(c-statistic 0.82; 95% CI, 0.76e0.89) and showed
excellent calibration (Hosmer Lemeshow p
value ¼ 0.95). Bootstrap analysis showed similar cstatistics. The test for equality of the AUC of the
multivariable model and the HF summed diagnostic
score showed no difference, thus conﬁrming reliability of the summed diagnostic score (p ¼ 0.54),
see Fig. 2 below.
The performance of the HF summed diagnostic
score at different predicted probabilities of HF in
the training dataset is shown in Table 4 below. The
HF summed diagnostic score had high accuracy at
the probabilities ranging from 40 to 80% with the
best performance at predicted probabilities of 40%e
60% where the sensitivity, speciﬁcity, positive predictive value and negative predictive value were
70.5%, 81.1%, 79.7% and 72.3% respectively with
accuracy of 75.7%. The HF summed diagnostic score
demonstrated excellent calibration (Hosmer Lemeshow goodness of ﬁt p ¼ 0.31) and similar

discrimination (c-statistic 0.73; 95%CI 0.60 to 0.87)
when applied to the testing dataset and bootstrap
analysis showed similar c-statistics as shown in
Fig. 3 below. We then tested the model again in the
whole original dataset of 202 participants using kfold cross validation bootstrap analysis as shown in
Fig. 4. Here again, the model exhibited satisfactory
discrimination with cvAUC of 0.80 (bootstrapped
bias corrected 95%CI 0.70 to 0.84). The relationship
of the HF summed diagnostic score with predicted
probabilities of HF presence in the whole of RISKHHF study is shown in Fig. 5 below. The graph
shows increasing probability of HF with increase in
the summed diagnostic score with a score of 6
predicting HF correctly 100%.
3.3. Performance of the HF summed diagnostic
score in the ECG-Hypertension validation cohort
Finally, we examined the performance of the
model in the validation dataset of the ECG-Hypertension Audit. The clinical characteristic of the
subjects in the ECG-Hypertension audit is shown in
Table 5 below. The mean age of the participants was
69.7 years with 42% males. The prevalence of HHF
was 33.7%.
In this validation cohort, the electrocardiographic
model also showed excellent discrimination (c-statistic 0.79; 95%CI 0.74 to 0.84) as shown in Fig. 6. Kfold cross validation analysis conﬁrmed the internal
validity of the model in this validation cohort
(cvAUC of 0.79; bootstrapped bias corrected 95%CI
0.68 to 0.80, HosmereLemeshow statistic for goodness of ﬁt; p ¼ 0.17), see Fig. 7.
The performance of the model was again tested
across range of different predicted probability of HF
as displayed in Table 6 below. The model
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Fig. 2. ROCs curve of the regression model (xb) and the derived HF summed diagnostic rule score with c-statistics of training dataset of random sample
of 152 participants; p value for equality of ROCs ¼ 0.54 (HosmereLemeshow statistic for goodness of ﬁt of model p ¼ 0.90 for regression model;
HosmereLemeshow statistic for goodness of ﬁt of the HF prediction score p ¼ 0.95 for regression model).
Table 3. The HF summed diagnostic rule score.
ECG Variable

b coefficient (95% CI)

Points

Sinus Tachycardia
Arrhythmia
Conduction abnormality
Left ventricular hypertrophy
Summed total diagnostic score

2.04
1.97
1.23
1.50
6

2
2
1
1

(0.83,
(0.94,
(0.19,
(0.62,

3.25)
2.99)
2.27)
2.38)

demonstrated good sensitivity and speciﬁcity within
the range of probability of HF of 30e60%.

4. Discussion
The mean age of the cases and controls in this
study is 62.5 ± 14.3 years and 60.7 ± 13.0 respectively. This is in tandem with the ﬁndings by
Akintunde [15]and Mene-Afejuku et al. [12] who

have reported a higher mean age of 62.1 ± 14.2 years
and 64.56 ± 11.85 years respectively among patients
with hypertensive heart failure. The age of the hypertension group here is higher than that reported
by most investigators in Nigeria [39,40]. However,
this is because they were matched with the cases
who had a higher age.
The electrocardiographic patterns seen in those
with HF in our study is in tandem with reports by
other investigators. The commonest ECG patterns
in both groups were LVH, LAD, LAE, arrhythmia,
conduction abnormalities and sinus tachycardia.
Olubodun et al. reported that the commonest ECG
abnormalities in patients with hypertensive HF was
LVH and left atrial enlargement which were seen in
76.7% of the subjects [41]. Karaye et al. [42] in Kano
reported that LVH was the commonest ﬁnding in

Table 4. HF summed diagnostic rule score performance according to predicted probability of HF in the RISK-HF training dataset.
Predicted probability of HF

Sensitivity (%)

Specificity (%)

PPV (%)

NPV (%)

Proportion correctly identified (%)

20%
30%
40%
50%
60%
70%
80%
90%

93.6
93.6
70.5
70.5
70.5
59.0
59.0
29.5

37.8
37.8
81.1
81.1
81.1
91.9
91.9
98.6

61.3
61.3
79.7
79.7
79.7
88.5
88.5
95.8

84.8
84.8
72.3
72.3
72.3
68.0
68.0
57.0

66.4
66.4
75.7
75.7
75.7
75.0
75.0
63.2

4.1. ECG as a diagnostic tool for HF in
hypertension

Fig. 3. HF summed diagnostic rule score performance in the test dataset
of 50 participants (HosmereLemeshow statistic for goodness of ﬁt of
model p ¼ 0.31; c statistic 0.73, 95%CI of c-statistic 0.60, 0.87).

both HFrEF and HFpEF occurring in 77.5% and 50%
respectively. In a study of HF patients in Ghana,
Owusu et al. [43] reported presence of abnormal
ECG patterns in 93% of 394 subjects studied which
is similar to the 98% found in our study. In Owusu
et al., the commonest abnormalities were LVH
(43.7%), LAD (39.6%), left bundle branch block
(19.2%), LAE (25.6%), premature ventricular ectopics
(11.2%) and atrial ﬁbrillation (8.9%) [43]. Agumuoh
et al. observed that sinus tachycardia, atrial ﬁbrillation and left axis deviation were commoner in
patients with hypertensive HF compared with those
with hypertension [8].

Heart failure remains an enigmatic diagnosis in
low resource settings in sub-Saharan Africa where
access to cardiology specialist services is limited to
tertiary hospitals. The development of a simple
clinical HF diagnostic score using a test as simple as
the ECG for stratiﬁcation of those at high risk of
heart failure has the potential to facilitate early
treatment and secondary preventive health services.
The electrocardiogram is a cheap and widely available test which is easily interpreted by technicians
and other ancillary health workers.
In this study, we have shown the increased frequency of various electrocardiographic abnormalities in individuals with HHF. Furthermore, our HF
summed diagnostic score consisting of sinus tachycardia, rhythm abnormalities, conduction abnormalities and LVH showed excellent discrimination
for the diagnosis of HF and has good internal and
external validity in cohorts of patients with hypertension. In low risk individuals of both the derivation and validation cohorts, the sensitivity of our
diagnostic score was 100% and is similar to the
Framingham criteria for HF diagnosis in this regard.
However, in these low risk individuals, the speciﬁcity of the model was very low and up to half to
one-third of patients with predicted probability of
HF of 20% would be misclassiﬁed. As expected, in
high-risk individuals with high pre-test probability
of HF of 90%, the speciﬁcity was 98.6% in the
training subset of the derivation cohort and 99.5% in
the validation cohort. In individuals with intermediate pre-test probability of HF, our electrocardiographic HF score showed high diagnostic accuracy
and good sensitivity and speciﬁcity. This has signiﬁcant clinical implication in general outpatient
clinics and low resource settings where there is

120

HF probability (%)

100

80

60

40

20

0
0

Fig. 4. HF summed diagnostic rule score performance using k-fold cross
validation in the whole RISK-HHF dataset of 202 participants (Bootstrapped bias corrected 95%CI of c-statistic 0.70, 0.84)
HosmereLemeshow statistic for goodness of ﬁt of model p ¼ 0.85.

1

2

3

4

5

6

HF diagnosc rule score

Fig. 5. Relationship of HF summed diagnostic rule score with probability
of presence of heart failure in the whole RISK-HHF dataset.
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Table 5. Clinical characteristics of participants in the ECG-Hypertension Audit (data are summarized as % for categorical variables and
mean ± SD for continuous variables).
Variables

N ¼ 377

Age
Male
Low education (below tertiary education)
Diabetes
Kidney disease
Ever smoked
Ever consumed alcohol
Heart failure diagnosis
BMI (kg/m2)
Pulse (/min)
SBP (mmHg)
DBP (mmHg)
Sinus tachycardia
Atrial ﬁbrillation
APCs
PVCs
Any arrythmia
Conduction abnormality
LAD
LAE
LVH
QRS duration (ms)
QTc interval (ms)

67.9 ± 35.8
158 (42)
255 (70.2)
54 (16.9)
13 (3.4)
42 (11.2)
110 (29.4)
127 (33.7)
28.3 ± 6.5
84.3 ± 15.7
138.1 ± 26.7
81.3 ± 13.0
54 (15.8)
20 (5.9)
41 (12.1)
30 (8.8)
62 (18.5)
92 (27.0)
129 (37.8)
112 (33.5)
152 (45.2)
93 ± 57.5
435.7 ± 71.6

diagnostic uncertainty. In this instance, an electrocardiogram has value in the stratiﬁcation of patients
for specialist referral and commencement of
appropriate therapy. The wide range of abnormal
ECG ﬁndings seen in the group with HF lends
credence to the view that the ECG is a cheap and
reliable diagnostic and prognostic tool in the evaluation of patients at high risk of HF. This is especially true of bundle branch blocks, PVCs, PACs,
atrial ﬁbrillation, which often herald incipient failure. Indeed, this has been shown in earlier studies

Fig. 6. HF summed diagnostic rule score performance in the ECG-Hypertension Audit dataset (95%CI of c-statistic 0.74, 0.84).

like the Framingham study. Electrocardiographic
LVH has been shown in the Framingham study to
be an independent predictor of HF and HF mortality
and corroborated in later studies [44,45]. Gencer
et al. [46] also reported that major ECG abnormalities like LVH and atrial ﬁbrillation were predictive
of HF incidence. In the MESA study, LBBB (a type of
conduction abnormality) was associated with 4-fold
increased risk of incident HF while LAD and LVH
were each associated with 1.6- and 1.9-fold
increased risk of incident HF [45]. Our study has
also corroborated the increased risk associated with
conduction abnormalities. Whether electrocardiographic abnormalities are a result of progressive
myocardial dysfunction, causation of dissociation in
electromechanical activation and conduction in
heart failure or both is difﬁcult to determine [7].
However, mechanistic studies suggest that electrocardiographic abnormalities develop early in the
progression of HF and abnormalities of electrical
coupling are harbingers of dangerous ventricular
rhythms and ventricular dis-synchrony which have
been associated with worse prognosis in patients
with HF [47]. LVH is the harbinger of electrical and
mechanical remodelling that occurs in HF. Sustained tachycardia provides a substrate for rhythms
like atrial ﬁbrillation and ventricular tachycardias
which have been implicated in the electrical
remodelling and “tachycardia induced cardiomyopathy that occurs in the transition to HF and they
infact cause HF on their own in patients who already
have structural heart disease especially left ventricular hypertrophy [47]. Findings from the Framingham and MESA studies support this pathway
[44,45]. Thus, early detection of these rhythm and

Fig. 7. HF summed diagnostic rule score performance using K fold cross
validation in the ECG-Hypertension Audit dataset (Bootstrapped bias
corrected 95%CI interval of c-statistic 0.68, 0.80) HosmereLemeshow
statistic for goodness of ﬁt of model p ¼ 0.17.

Table 6. HF summed diagnostic rule score according to predicted probability of HF in ECG-Hypertension Audit dataset.
Predicted probability of HF

Sensitivity (%)

Specificity (%)

PPV (%)

NPV(%)

Correctly classified (%)

20%
30%
40%
50%
60%
70%
80%
90%

93.4
65.6
65.6
46.7
46.7
18.8
18.8
2.5

48.1
75.5
75.5
90.4
90.4
97.6
97.6
99.5

51.3
61.1
61.1
74.0
74.0
82.1
82.1
75.0

92.6
78.9
78.9
74.3
74.3
67.2
67.2
63.5

64.8
71.8
71.8
74.2
74.2
68.5
68.5
63.6

conduction abnormalities can help identify patients
who are increased risk before they develop heart
failure. ECGs are attractive cheap and easily readable tests that may be used in stratiﬁcation of patients who may need specialised care.
The strength of this study includes the matching
of cases with control in the derivation RISK-HHF
cohort which reduces the confounding effects of age
and sex in heart failure risk. In addition, by using
easily measured electrocardiographic proﬁling to
generate a HF diagnostic score in characterising the
patients, this can be readily deployed in the day-today clinical assessment of patients and their stratiﬁcation. Furthermore, the good internal validity of
the HF summed score and its conﬁrmation in an
independent validation cohort makes the likelihood
of selection bias very low. More so, the diagnosis of
HF was made via comprehensive clinical and imaging assessment based on current guidelines. The
individuals in the validation cohort represent dayto-day clinical practice. Testing the HF summed
score at different levels of predicted HF probability
also allowed diagnostic accuracy of the model to be
determined.
This study is not without limitations. First, the
derivation RISK-HHF cohort is a highly selected
group of patients, though efforts have been made to
reduce confounding. Thus, the ﬁnding is only generalisable to patients with hypertension who are at
risk of HF. Also, the model requires further validation in larger cohorts especially in the community.
This model is not intended to supplant comprehensive clinical assessment in specialist setting and
we have not explored the additive roles of other
markers e.g NT-Pro-BNP assay and serum creatinine. We do not know yet the value of this model in
individuals of other racial identities. As mentioned
earlier, it is difﬁcult to conclude whether the electrocardiographic risk factors are actual risk factors
or markers of an already established state. A cohort
study is better to investigate these relationships.
Coronary angiography was not done to completely
rule out co-existing ischaemic heart disease, however, the deﬁnitions used to exclude ischaemic heart

disease have been used in other studies in this
population and the probability of misclassiﬁcation
of patients is low. Moreover, the prevalence of
ischaemic heart disease in Nigeria is still low and
hypertension still accounts for most of the HF in our
population.

5. Conclusion
In conclusion, we have shown in this study that a
simple ECG based score derived from a logistic
regression model consisting of sinus tachycardia,
arrhythmia, conduction abnormalities and LVH is
diagnostic of HF in individuals with hypertension.
This is independent of age and sex. Regular routine
electrocardiography should be done in patients on
treatment for hypertension to identify early, these
markers of HF. This will aid early detection and
secondary prevention. A comprehensive HF registry
should be established in all tertiary health institutions. This will help in further large-scale
studies and validation of these results. Finally, a
larger caseecontrol study or even a cohort study is
needed to conﬁrm the ﬁndings of this research.
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